<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04676256</url>
  </required_header>
  <id_info>
    <org_study_id>P170408J</org_study_id>
    <secondary_id>IDRCB</secondary_id>
    <nct_id>NCT04676256</nct_id>
  </id_info>
  <brief_title>Early VItrectomy in DENse Spontaneous Vitreous HEmorrhage</brief_title>
  <acronym>EVIDENSE</acronym>
  <official_title>Comparaison de la Vitrectomie précoce et de la Surveillance Simple Dans la Prise en Charge Des hémorragies du vitré spontanées EVIDENSE Early VItrectomy in DENse Spontaneous Vitreous HEmorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the protocol is to compare the ocular outcomes after spontaneous vitreous&#xD;
      hemorrhage treated with an early vitrectomy versus ultrasound monitoring with late&#xD;
      vitrectomy.&#xD;
&#xD;
      The hypothesis is that an early vitrectomy could decrease the rate of retinal detachment&#xD;
      occurring after a spontaneous vitreous hemorrhage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the protocol is to compare the ocular outcomes after spontaneous vitreous&#xD;
      hemorrhage treated with an early vitrectomy versus ultrasound monitoring with late&#xD;
      vitrectomy.&#xD;
&#xD;
      The hypothesis is that an early vitrectomy could decrease the rate of retinal detachment&#xD;
      occurring after a spontaneous vitreous hemorrhage.&#xD;
&#xD;
      Scientific background Spontaneous vitreous hemorrhage may occur after spontaneous posterior&#xD;
      vitreous detachment and causes retinal break and retinal detachment in about 70% and 40% of&#xD;
      cases respectively. The fundus examination and ultrasound have limited sensitivity to detect&#xD;
      retinal breaks in these cases. Some retrospective studies have highlighted the benefit of an&#xD;
      early vitrectomy for decreasing the rate of visual loss due to retinal detachment in these&#xD;
      cases. However, to date, there is no national or international consensus regarding the&#xD;
      management of spontaneous vitreous hemorrhage and the timing of vitrectomy.&#xD;
&#xD;
      Study design Prospective randomized clinical trial Primary objective To compare the results&#xD;
      of an early vitrectomy versus ultrasound and fundus observation in spontaneous vitreous&#xD;
      hemorrhage.&#xD;
&#xD;
      Secondary objectives To evaluate the rate of retinal complications in spontaneous vitreous&#xD;
      hemorrhage treated either with early or delayed vitrectomy.&#xD;
&#xD;
      To evaluate the rate of visual loss in spontaneous vitreous hemorrhage treated either with&#xD;
      early or delayed vitrectomy.&#xD;
&#xD;
      Primary criteria Rate of retinal detachment in eyes with spontaneous vitreous hemorrhage&#xD;
      treated with early vitrectomy versus ultrasound observation at 6-month follow-up Secondary&#xD;
      criteria Rate of retinal breaks and vitreo-retinal proliferation in eyes with spontaneous&#xD;
      vitreous hemorrhage treated with early vitrectomy versus ultrasound observation at 6-month&#xD;
      follow-up Visual acuity and rate of eyes with a loss of 5 letters or more among eyes with&#xD;
      spontaneous vitreous hemorrhage treated with early vitrectomy versus ultrasound observation&#xD;
      at 6-month follow-up Participants Patients with a spontaneous vitreous hemorrhage secondary&#xD;
      to posterior vitreous detachment, with a reduced visibility of the fundus Inclusion criteria&#xD;
&#xD;
        -  Age &gt; or = 18 years old&#xD;
&#xD;
        -  Spontaneous vitreous hemorrhage which is 1/ secondary to posterior vitreous detachment;&#xD;
           2/ acute: which duration is &lt; 15 days, 3/ dense: reduced visibility of the fundus&#xD;
&#xD;
      Exclusion criteria:&#xD;
&#xD;
        -  Retinal detachment at the initial examination&#xD;
&#xD;
        -  Any history of vascular retinal disease (diabetic retinopathy, retinal vein occlusion…)&#xD;
&#xD;
        -  Any history of uveitis, age-related macular degeneration&#xD;
&#xD;
        -  History of a recent ocular traumatism (&lt; 3 months)&#xD;
&#xD;
        -  History of a recent retinal laser treatment (&lt; 3 months) or vitreo-retinal surgery (&lt; 3&#xD;
           months)&#xD;
&#xD;
        -  Absence of consent Experimental group Eyes with spontaneous vitreous hemorrhage treated&#xD;
           with early vitrectomy (n = 63) Active Comparator group Eyes with spontaneous vitreous&#xD;
           hemorrhage only observed using fundus examination and B-ultrasound (n = 63) Study&#xD;
           duration Inclusion: 12 months Participation: 6 months Total duration: 18 months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2021</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of retinal detachment</measure>
    <time_frame>6 months after intervention</time_frame>
    <description>number of eyes with a retinal detachment in each group. The presence of retinal detachment will be assessed on fundus examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of retinal breaks</measure>
    <time_frame>6 months after intervention</time_frame>
    <description>number of eyes with a retinal breaks in each group. The presence of retinal breaks will be assessed on fundus examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate vitreo-retinal proliferation</measure>
    <time_frame>6 months after intervention</time_frame>
    <description>number of eyes with a vitreo-retinal proliferation in each group. The presence of vitreo-retinal proliferation will be assessed on fundus examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>6 months after intervention</time_frame>
    <description>visual acuity will be measured using Snellen and/or ETDRS chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of eyes with a loss of 5 letters or more</measure>
    <time_frame>6 months after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of cataract</measure>
    <time_frame>6 months after intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Spontaneous Vitreous Hemorrhage</condition>
  <condition>Retinal Break</condition>
  <condition>Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>Early Vitrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental arm will be treated with early vitrectomy early vitrectomy 7 days after vitreous hemorrhage diagnosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active comparator arm will have fundus and ultrasound observation. Late vitrectomy may be indicated after 3 months of follow-up if needed.&#xD;
Late vitrectomy will be performed in case of persistant vitreous hemorrhage after 3 months of folllow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early vitrectomy</intervention_name>
    <description>Eyes with spontaneous vitreous hemorrhage treated with early vitrectomy (n = 63)</description>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_label>Early Vitrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; or = 18 years old&#xD;
&#xD;
          -  Spontaneous vitreous hemorrhage which is :&#xD;
&#xD;
               1. secondary to posterior vitreous detachment;&#xD;
&#xD;
               2. acute: which duration is &lt; 15 days,&#xD;
&#xD;
               3. dense: reduced visibility of the fundus&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Retinal detachment at the initial examination&#xD;
&#xD;
          -  Any history of vascular retinal disease (diabetic retinopathy, retinal vein&#xD;
             occlusion…)&#xD;
&#xD;
          -  Any history of uveitis, age-related macular degeneration&#xD;
&#xD;
          -  History of a recent ocular traumatism (&lt; 3 months)&#xD;
&#xD;
          -  History of a recent retinal laser treatment (&lt; 3 months) or vitreo-retinal surgery (&lt;&#xD;
             3 months)&#xD;
&#xD;
          -  Absence of oral and written consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aude COUTURIER, MD, PhD</last_name>
    <phone>+33149952474</phone>
    <email>aude.couturier@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Lariboisiere</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aude Couturier, Dr</last_name>
      <phone>+33(0) 1.49.95.24.74</phone>
      <email>aude.couturier@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 31, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>spontaneous vitreous hemorrhage</keyword>
  <keyword>retinal break</keyword>
  <keyword>retinal detachment</keyword>
  <keyword>ultrasound</keyword>
  <keyword>vitrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Vitreous Hemorrhage</mesh_term>
    <mesh_term>Retinal Perforations</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

